Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03567720
Title Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors OncoSec Medical Incorporated
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS


No variant requirements are available.